The president of the UCLA Health System, which is still contending with the outbreak of a superbug that infected 7 patients and killed 2, is stepping down from his position for a new appointment as president and chief executive officer of Geisinger Health System.
The president of the UCLA Health System, which is still contending with the outbreak of a superbug that infected 7 patients and killed 2, is stepping down from his position for a new appointment as president and chief executive officer (CEO) of Geisinger Health System.
David T. Feinberg, MD, MBA will succeed Glenn Steele, Jr, MD, PhD. Dr Feinberg, who will join Geisinger May 1, 2015, has been named to Modern Healthcare’s 50 Most Influential Physician Executives.
“It is important to me to not only continue, but also expand Geisinger’s work in patient care, research, education, innovation and community service, and I look forward to continuing Geisinger’s trajectory of achievement upward,” Dr Feinberg said in a statement.
In addition to being CEO of the UCLA Hospital System, he is currently the associate vice chancellor for UCLA Health Sciences in California. He has served many roles with UCLA over the years, including vice chair for clinical affairs in the department of psychiatry and behavioral sciences, and medical director of managed care/outpatient services at the UCLA Neuropsychiatric Institute and Hospital.
Dr Feinberg has been named Medical Center CEO of the Year by The Los Angeles Business Journal and Outstanding Physician of the Year by the Southern California Psychiatric Society and won many other awards, as well as authored numerous articles and chapters. He specializes in psychiatry and child psychiatry.
Dr Steele will continue as chairman of xG Health Solutions, a venture of Geisinger that helps healthcare organizations create value and improve quality.
“It has been my extraordinary privilege to lead the organization from a highly respected regional provider to a nationally recognized system,” he said. “I wish Dr. Feinberg well as he continues to build upon Geisinger’s unique position, history and track record of success well into the future, and I will do all I can to help him transition to his new position.”
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More